Current location - Education and Training Encyclopedia - Resume - Brief introduction of scientific research in Xu Feng
Brief introduction of scientific research in Xu Feng
1, Oncology and Social Psychopharmacology

2. Tissue engineering and regenerative medicine

Academic position: Member of the Professional Committee of Tumor Pharmacology of Chinese Pharmacology Society.

Standing Committee member of tumor pharmacology Committee of Guangdong Pharmacology Society

Editorial Committee of Pharmacy Today of Chinese Pharmaceutical Association 1, Handbook of Clinical Prescription Management (2005) Guangdong Science and Technology Press.

2. Unconventional drugs to treat diseases (1998, version1; China Medical Science and Technology Press (2nd Edition, 2005).

3. Drug Treatment of Children's Diseases (1994) South China University of Technology Press 1. Therapeutic drug monitoring of cyclosporine after renal transplantation. (1994) The third prize of the army's scientific and technological progress.

2. Determination of body fluid concentration and pharmacokinetics of anticancer drugs. (1995) The third prize of the army's scientific and technological progress.

3. On the theory of social psychopharmacology and its application in clinical pharmacy. (2009) Second Prize of Guangdong Medical Science and Technology 1. The basic research of depression changing the pharmacokinetics of fluorouracil by influencing dihydropyrimidine dehydrogenase is 20 10-20 12, and the national research fund for returned overseas students is 30,000 yuan.

2.R&D and the industrialization of nano bionic artificial skin scaffold materials 20 10-20 13 Guangdong Academy of Sciences comprehensive strategic cooperation project of 300,000 yuan.

3. Reconstruction of therapeutic breast tissue with adipose-derived stem cells and self-assembled polypeptide scaffolds. Guangzhou Returned Overseas Students Start-up Fund 2009-201230,000 Yuan.

He has been engaged in medical research for many years and published more than 20 papers in international SCI magazines (Oncology, Br J Clin Pharm, Nanotechnology, etc.). ) As the first author and correspondent. Won the 12 World Pharmacology Congress Award (1994), the Seventh International Infectious Diseases Congress Award (1995), the third prize of the military scientific and technological progress (1994, 1995), and the International Pharmacology Federation/kloc-0. The first prize of Academic Conference of Chinese Journal of Internal Medicine of Chinese Medical Association, Contemporary Progress of Lipid Regulation and Prevention of Coronary Heart Disease (1998), Outstanding Postgraduate Award of Union Medical College (1999, 2000) and Outstanding Pharmacist Award of Chinese Pharmaceutical Association (2005). In 2009, he returned to China after completing postdoctoral research in the United States, and successively undertook a number of projects, such as the national research start-up fund for returned overseas students, the opening project of South China State Key Laboratory of Oncology, the comprehensive strategic cooperation project of Guangdong Academy of Sciences, and the Guangdong Provincial Hospital Drug Research Fund.